NPR: Vaccine Cost-Benefit Analysis Complicates GuidelinesNPR: Rising Costs Complicate Vaccine Guidelines
The group that advises the U.S. government on vaccination thinks some new vaccines may not be worth the cost. In 2009, the Advisory Committee on Immunization Practices, or ACIP, decided it's not cost effective to routinely vaccinate boys for human papillomavirus, though they do recommend the vaccine for girls. Now the group is struggling to decide whether infants and toddlers should get costly new vaccines to prevent a form of meningitis caused by bacteria (Hamilton, 7/18). This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.